Determinants governing the CYP74 catalysis: Conversion of allene oxide synthase into hydroperoxide lyase by site-directed mutagenesis  by Toporkova, Yana Y. et al.
FEBS Letters 582 (2008) 3423–3428Determinants governing the CYP74 catalysis: Conversion of allene
oxide synthase into hydroperoxide lyase by site-directed mutagenesis
Yana Y. Toporkova, Yuri V. Gogolev, Lucia S. Mukhtarova, Alexander N. Grechkin*
Kazan Institute of Biochemistry and Biophysics, Russian Academy of Sciences, P.O. Box 30, 420111 Kazan, Russia
Received 4 August 2008; revised 26 August 2008; accepted 2 September 2008
Available online 18 September 2008
Edited by Michael R. SussmanAbstract Bioinformatics analyses enabled us to identify the
hypothetical determinants of catalysis by CYP74 family en-
zymes. To examine their recognition, two mutant forms F295I
and S297A of tomato allene oxide synthase LeAOS3
(CYP74C3) were prepared by site-directed mutagenesis. Both
mutations dramatically altered the enzyme catalysis. Both mu-
tant forms possessed the activity of hydroperoxide lyase, while
the allene oxide synthase activity was either not detectable
(F295I) or signiﬁcantly reduced (S297A) compared to the wild-
type LeAOS3. Thus, both sites 295 and 297 localized within
the ‘‘I-helix central domain’’ (‘‘oxygen binding domain’’) are
the primary determinants of CYP74 type of catalysis.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The plant lipoxygenase signalling cascade and its products,
oxylipins, play a crucial role in plant cell signalling and defence
[1–4]. The diversity of oxylipins is established by lipoxygenases
along with the enzymes of the unique CYP74 family of P450
macrofamily. There are three known kinds of CYP74 enzymes:
two dehydrases, namely allene oxide synthase (AOS) and divi-
nyl ether synthase (DES) and one isomerase, called ‘‘hydroper-
oxide lyase’’ (HPL). The HPL catalyzes the homolytic
isomerization of fatty acid hydroperoxide into the short-lived
hemiacetal [5,6].
A number of CYP74 genes have been cloned [3,4] and the
properties of the recombinant proteins have been studied.
No X-ray studies of CYP74 3D structure have been reported
yet. All P450s have some essential conserved domains in their
primary structures, in particular, several ‘‘substrate recogni-
tion sites’’ (SRS) [7]. Some of them constitute the walls of
the P450 cavity, for instance the I-helix [8–10]. Its domainAbbreviations: AOS, allene oxide synthase; HPL, hydroperoxide lyase;
DES, divinyl ether synthase; WT, wild type; IHCD, I-helix central
domain; SRS, substrate recognition site; 9-HPOD, (9S,10E,12Z)-9-
hydroperoxy-10,12-octadecadienoic acid; 13-HPOD, (9Z,11E,13S)-13-
hydroperoxy-9,11-octadecadienoic acid; IMAC, immobilized metal
aﬃnity chromatography; TMS, trimethylsilyl
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I-helix (we will call it the ‘‘I-helix central domain’’, IHCD),
is involved in the monooxygenase catalysis. The IHCD of
monooxygenases (having a conserved motif A/G-G-X-D/E-
T/S-T/S) is called the ‘‘oxygen binding and activation do-
main’’. Unlike the monooxygenases, CYP74s do not use the
molecular oxygen as a substrate. Instead of that, CYP74s have
a single substrate, fatty acid hydroperoxide. We hypothesized
that the IHCDs of CYP74s interacts with the hydroperoxide
function of the substrate and plays a key role in CYP74 catal-
ysis. To examine this hypothesis, we performed the site-direc-
ted mutagenesis within the putative IHCD of cDNA of
tomato allene oxide synthase LeAOS3 (CYP74C3). The com-
parison of I-helix sequences of CYP74s (Fig. 1) enabled us
to choose two target sites for mutations. Two obtained mu-
tants F295I and S297A exhibited dramatic alterations in catal-
ysis compared to the wild-type (WT) LeAOS3. Both mutants
possessed the activity of a HPL, while the AOS activity was
either almost absent (F295I) or strongly diminished (S297A).2. Materials and methods
2.1. Materials
Linoleic and a-linolenic acids, as well as soybean lipoxygenase type
V were purchased from Sigma. Silylating reagents were purchased
from Fluka (Buchs, Switzerland). Authentic samples of 9-oxononanoic
acid and 9-hydroxynonanoic acid were prepared as described before
[6]. (9S,10E,12Z)-9-hydroperoxy-10,12-octadecadienoic acid (9-
HPOD) was prepared by incubation of linoleic acid with tomato fruit
lipoxygenase at 0 C, pH 6.0, under continuous oxygen bubbling.
(9Z,11E,13S)-13-hydroperoxy-9,11-octadecadienoic acid (13-HPOD)
was obtained by incubations of linoleic and a-linolenic acids, respec-
tively, with soybean lipoxygenase type V. All hydroperoxides were
puriﬁed by normal phase HPLC.
2.2. Bioinformatics methods for CYP74 structure analysis
The primary structures of CYP74s were aligned using NCBI and
PlantGDB BLAST searches. The secondary structures, particularly
the assignment of I-helixes, were analyzed with PSIPRED protein
structure prediction server [11,12]. The 3D modelling of CYP74s was
performed using EsyPred3D program [13] and the available X-ray
models for some animal P450s as the reference 3D structures.
2.3. Expression and puriﬁcation of recombinant LeAOS3
LeAOS3 cDNA has been cloned into the vector pET23b (Novagen/
Merck) to yield a fusion protein (55.51 kDa) with a His6 tag at the C
terminus of the protein. The His-tagged recombinant LeAOS3 (WT
and mutant forms) were expressed and prepared as described before
[14]. His-tagged recombinant proteins were puriﬁed by immobilized
metal aﬃnity chromatography (IMAC) using the cobalt TALON
metal aﬃnity resin (Clontech) as described before [15]. The homo-
geneity of puriﬁed proteins was conﬁrmed by SDS–PAGE. Proteinblished by Elsevier B.V. All rights reserved.
Fig. 1. Alignment of the central parts of I-helixes of CYP74 enzymes. The putative IHCD is marked with asterisks at the top. Pg, Psidium guajava;
Le, Lycopersicon esculentum; Ca, Capsicum annuum; Mt,Medicago truncatula; Cm, Cucumis melo; Os, Oryza sativa; St, Solanum tuberosum; Zm, Zea
mays; Pa, Parthenium argentatum; Lu, Linum usitatissimum; As, Allium sativum; and Nt, Nicotiana tabacum.
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measured with Varian Cary 50 spectrophotometer by the decrease of
9-HPOD absorbance at 234 nm [15].
2.4. Site-directed mutagenesis
Genes of the mutant LeAOS3, F295I and S297A, were constructed
using the QuickChange XL Site-Directed Mutagenesis Kit with the
recommended procedures (Stratagene) and primers listed in Table 1.
The mutations were conﬁrmed by DNA sequencing.
2.5. Incubations of recombinant LeOAS3
The recombinant LeAOS3 or its mutants (10 lg of protein) were
incubated with 100 lg of 9-HPOD or 13-HPOD in phosphate buﬀer
(2 ml), pH 7.0, 4 C, for 15 min. The products were extracted puriﬁed
with solid phase cartridges, methylated and trimethylsilylated as de-
scribed before [15], followed by GC–MS analyses. When speciﬁed,
the products were reduced with NaBH4 or NaB
2H4 after extraction,
then methylated and trimethylsilylated. Separate incubations with re-
combinant proteins (10 lg of each protein) were performed in the same
way with [1-14C]9-HPOD (18.5 KBq, 55.5 KBq/lmol).
2.6. Instrumental methods
Products (without or with the preliminary NaBH4 or NaB
2H4 reduc-
tion) were analyzed as methyl esters/TMS derivatives by GC–MS as
described before [15]. Alternatively, products (as methyl esters) were
analyzed by the reversed phase radio-HPLC as described before [16].3. Results
3.1. Assignment of the IHCD
The exact recognition of the IHCDs within the CYP74 pri-
mary sequences is hindered by the absence of X-ray data for
CYP74s and insuﬃcient homology between CYP74s and mon-
ooxygenases. Before Matsui et al. [17] attributed the IHCD of
Capsicum annuum HPL to sites 294–299 (GGFTIF motif),
which are homologous to AA residues 299–305 (GGLKVF)
of LeAOS3. Hughes et al. [18] assigned the IHCD ofMedicagotruncatula HPL CYP74C3 to the sites 285–288 (motif NAFG),
homologous to sites 296–299 (NSYG) of LeAOS3.We assigned
the I-helix of LeAOS3 to the sites 282–315 and the IHCD to the
sites 293–298 (motif AGFNSY). Our assignment was substan-
tiated by (1) numerous alignments of CYP74s (examples are
shown in Fig. 1) and some other P450s; (2) the analyses of
CYP74 secondary structure; (3) high variability of IHCD of
CYP74s, including the non-synonymous substitutions; (4) the
conserved peculiarities of separate CYP74 enzymes (AOS,
HPLs and DESs) (Fig. 1) and (5) the spatial positions of I-he-
lixes and IHCDs in the available X-ray models for P450s.
3.2. The choice of mutation sites
All AOSs have a conserved Ser/Thr residue in their IHCD
sequence (Fig. 1, a column highlighted in grey). For instance,
LeAOS3 has a Ser in position 297. In contrast, the same time,
almost all HPLs (except the MtHPL3 of M. truncatula and
MsHPL of Medicago sativa) possess Ala instead of Ser/Thr
at this site (Fig. 1). This Ser/Thr residue is also substituted
for Met/Ala in all DESs (Fig. 1). Thus, one could propose that
(1) this Ser/Thr residue is one of determinants of AOS type of
catalysis; (2) S297A mutation of LeAOS3 would alter the type
of enzyme catalysis. In view of these considerations, we pre-
pared the S297A mutant form of LeAOS3 by site-directed
mutagenesis.
Most of CYP74s contains two aromatic amino acid residues
in their IHCDs. For instance, LeAOS3 possesses one Phe 295
and one Tyr 298 residues (the last site contains Phe/Tyr/Trp in
all CYP74s). The ﬁrst residue like Phe 295 of LeAOS3 is con-
served in all known AOSs and HPLs (Fig. 1, a column high-
lighted in grey). In contrast, this Phe residue is substituted
for Ile in all DESs (Fig. 1). This diﬀerence prompted us to
examine the mutation of this site. Thus, we obtained and
examined the F295I mutant form of LeAOS3.
Table 1
PCR primers used for site-directed mutagenesis
Mutant F295I S297A
Sense primer CTTTGTTTTCCTAGCAGGAATCAATTCGTATGGCGGTTTG CCTAGCAGGATTCAATGCGTATGGCGGTTTGAAAGTG
Antisense primer CAAACCGCCATACGAATTGATTCCTGCTAGGAAAACAAAG CACTTTCAAACCGCCATACGCATTGAATCCTGCTAGG
Tm (C) 73 72
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When the WT LeAOS3 was incubated with 9-HPOD, the
major product was a-ketol (12Z)-9-hydroxy-10-oxo-12-octa-
decenoic acid (detected as Me ester TMS derivative)
(Fig. 2A). Its identiﬁcation is substantiated by mass spectral
data, coinciding with those described before [15]. This product
is formed through the hydrolysis of allene oxide, (12Z)-9,10-
epoxy-10,12-octadecadienoic acid [14,15]. Along with AOS
products, extremely little amount of HPL product 9-oxonona-
noic acid (as methyl ester) was detected (Fig. 2A). This result
indicates that the WT LeAOS3 produces a minority of 9-oxo-
nonanoic acid as a by-product. Nevertheless, AOS products
were predominant. Divinyl ethers were not detectable.
The F295I mutant form exhibited 13% of activity of the WT
LeAOS3. The analyses of products formed by F295I mutant
demonstrated a dramatic alteration in the type of catalysis.
The major AOS product, a-ketol was not detectable
(Fig. 2B). Instead, the F295I mutant produced the HPL prod-Fig. 2. Products of the WT LeAOS3 (A) and its mutant forms F295I (B) a
esters TMS derivatives). The recombinant proteins were incubated with 9-HP
are described under Section 2. Insert (top left): 256-fold scaled up fragmentuct 9-oxononanoic acid (Fig. 2B). This product was identiﬁed
by mass spectra of its methyl ester (Fig. 3A), and product of its
NaBH4 (Fig. 3B) and NaB
2H4 (Fig. 3C) reduction (9-hydroxy-
nonanoic acid) as methyl esters TMS derivatives. Considering
the detection limit for a-ketol Me/TMS (within the GC–MS se-
lected ion chromatogram, m/z 259), its possible abundance was
below 0.1% of peak area of 9-oxononanoic acid Me ester (esti-
mated by the integration of ion chromatogram, m/z 74). Divi-
nyl ethers were not detectable, too. These results indicate that
the mutation F295I transformed AOS into HPL, which exhib-
ited a remarkable speciﬁcity.
The S297A mutant exhibited 52% of the total WT LeAOS3
activity. This mutation signiﬁcantly altered the type of cataly-
sis, too. This mutant also possessed the HPL activity, produc-
ing 9-oxononanoic acid as a major product (Fig. 3C). The
S297A mutant possessed some remaining AOS activity, but
it was strongly decreased as compared to the WT LeAOS3
(Fig. 3C). The ratio of 9-oxononanoic acid to a-ketol producednd S297A (C). Selected ion GC–MS chromatograms of products (Me
OD. Conditions of incubation, extraction, derivatization and analyses
chromatogram (m/z 158) of the WT LeAOS3 products.
Fig. 3. The electron impact mass spectra of major product produced by LeAOS3 mutant forms F295I and S297A. (A) spectrum of 9-oxononanoic
acid (Me ester); (B and C) spectra of products of NaBH4 (B) and NaB
2H4 (C) reduction of 9-oxononanoic acid (as Me esters TMS derivatives).
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the WT LeAOS3.
The WT LeAOS3 utilizes both 9-HPOD and 13-HPOD
[14,15]. In contrast, both mutant forms F295I and S297A uti-
lized preferentially 9-HPOD. 13-HPOD was poor substrate for
both mutant forms (results not illustrated).4. Discussion
The obtained data demonstrate for the ﬁrst time the inter-
conversion of CYP74 enzymes caused by site-directed muta-
genesis. Both F295I and S297A single site mutations of
LeAOS3 (CYP74C3) turn the WT AOS into HPL. Apparently,
some other SRSs along with IHCD and SRS-4 also aﬀect the
CYP74 catalysis. Further works on site-directed mutagenesis
of CYP74s are needed to reveal these probable dependencies.
Nevertheless, the results of the present work unambiguously
demonstrate that the primary sequence of IHCD determines
the kind of catalysis by CYP74s. The IHCD can be considered
as the CYP74 ﬁngerprints, allowing one (as a rule) to predict
the type of catalysis from the primary sequence (Fig. 1).The data demonstrate that the catalytic mechanisms of
CYP74 enzymes are closely related. Recently the HPLs were
identiﬁed as isomerases catalyzing the homolytic isomerization
of fatty acid hydroperoxide into the unstable hemiacetal [5,6].
These data suggest that all CYP74 enzymes control the homo-
lytic rearrangement intermediated by alkoxy radical and an
epoxyallylic radical [3,5,6]. The results of site-directed muta-
genesis indicate that the epoxyallylic radical is the switching
point of CYP74 catalysis (Scheme 1). Depending on primary
sequence of IHCD (and, possibly, some other domains), the
epoxyallylic radical either loses a hydrogen atom to aﬀord al-
lene oxide, or undergoes the rearrangement into the vinyl ether
radical, which is then recombined with hydroxyl radical to af-
ford the hemiacetal [5,6], a primary HPL product (Scheme 1).
To our knowledge, no qualitative alterations of P450 catal-
ysis by site-directed mutagenesis have been reported before.
The previously described P450 mutant forms [19–24], including
the MtHPL mutant [18], possessed some alterations like the
change of substrate speciﬁcity or regiospeciﬁcity, but not the
qualitative transformations of catalysis (like the conversion
of dehydrase (AOS) into isomerase (HPL) in the present
work).
Scheme 1.
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1. The interconversion of CYP74 family enzymes by site-di-
rected mutagenesis was demonstrated for the ﬁrst time.
2. Two single site mutant forms F295I and S297A of LeOAS3
(CYP74C3) have been prepared.
3. Both mutant forms F295I and S297A possess the activity of
HPL, while the AOS activity was either strongly suppressed
(S297A), or almost absent (F295I).
4. Epoxyallylic radical, a central intermediate in CYP74 catal-
ysis, either loses one hydrogen atom, aﬀording the allene
oxide (WT enzyme), or undergoes the rearrangement into
the isomeric radical, which recombines with hydroxyl radi-
cal to form the hemiacetal, a primary HPL product (F295I
and S297A mutant forms).
5. The data of the site-directed mutagenesis conﬁrm the exis-
tence of close phylogenetic and evolutionary relations with-
in the CYP74 family.
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